Intravenous bolus administration of caffeine citrate in premature babies
The study presented here demonstrates that the administration of caffeine citrate (Peyona) as an intravenous bolus is safe and well tolerated by preterm infants. The rationale and advantages of bolus use in daily clinical practice are discussed.
Olayinka Ejiwumi, Stamatina Leontiadi, Deborah Hopper, Peter ReynoldsOr read this article in our
Tablet/iPad edition
